A 3-Month Non-Interventional Study of Asthmatics Treatment With Symbicort® Turbuhaler®

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00532922

Acronym

Symb NIS

Enrollment

310

Registered

2007-09-21

Start date

2007-04-30

Completion date

2007-11-30

Last updated

2009-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Brief summary

The purpose of this study is to investigate real practices of treatment with Symbicort Turbuhaler for 3 months in asthma and patient compliance.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

6 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Provision of informed consent 2. Asthmatics who has been prescribed Symbicort according to physician's judgement 3. Usage of Symbicort should follow local prescribing information

Exclusion criteria

1. Not being involved in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site) 2. No previous enrolment in the present study

Countries

China

Outcome results